Labs / ADME, DMPK & toxicology

Helix Biopharma
Toronto, ON, Canada · helixbiopharma.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Helix Biopharma is a clinical-stage oncology company developing novel therapies for difficult-to-treat cancers. It focuses on CEACAM6-targeted programs, including therapies for advanced solid tumors, non-small cell lung cancer, and leukemia relapse after allogeneic stem cell transplantation. The company is based in Vancouver, British Columbia, Canada.
They take quote requests by email.
What they offer
L-DOS47 development
Develops L-DOS47, a CEACAM6-targeted antibody-enzyme conjugate designed to counter tumor acidosis and improve responses to immunotherapy in advanced NSCLC.
LEUMUNA™ development
Develops LEUMUNA™, an oral immune checkpoint modulator for leukemia relapse following allogeneic stem cell transplantation.
GEMCEDA™ development
Develops GEMCEDA™, an oral gemcitabine-based therapy for advanced solid tumors.
CEACAM6-targeted pipeline development
Advances next-generation CEACAM6-targeted programs, including antibody-drug conjugates and radioligand therapeutics.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Recombinant protein
- Therapeutic areas
- oncology, solid tumors, non-small cell lung cancer, leukemia
- Sites
- Vancouver, Canada
- Address
- 789 West Pender Street, Suite 480, Vancouver, British Columbia, V6C 1H2
Public records
- Ownership
- HELIX BIOPHARMA CORP. · CA GLEIF
Similar labs. Venenum Biodesign, Aurigene Pharmaceutical Services, AxisPharm, Bio Synthesis
Found in a contract services directory. Listing built from helixbiopharma.com. Work here? Claim this listing.